MedPath

Transition From Adolescents to Adulthood for Patients With Congenital Heart Diseases

Not Applicable
Completed
Conditions
Congenital Heart Diseases
Interventions
Other: Standard follow-up
Other: Therapeutic education
Registration Number
NCT03005626
Lead Sponsor
University Hospital, Montpellier
Brief Summary

The Investigators aim to measure the impact of a transition program in congenital cardiology in terms of health-related quality of life.

Detailed Description

The number of adults with congenital heart diseases (CHD) is increasing. However, many young adults are lost to follow-up even in experienced tertiary care centers. American and European guidelines recommend to improve the management of young adults with CHD. Structured therapeutic education programs are therefore needed to optimize the transfer to adult healthcare. Our tertiary care CHD center recently implemented a transition program and simultaneously investigators decided to measure its impact. Indeed investigators need data from randomized trials in this filed. After previous controlled quality of life studies among children and adults with CHD, investigators chose to use the health-related quality of life (HR-QoL) as primary endpoint in this randomized study to focus on patient related outcomes.

The investigators assume that patients who participate in this program will improve their quality of life compared to controls. If investigators demonstrate the benefit of this program, it will have important consequences for patients with CHD and eventually for patients with other chronic medical conditions.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patient from 13 years to 25 years inclusive.
  • Carrying of Congenital Heart Disease as defined in the International Classification.
  • Possible follow-up for one year on one of the three hospital center.
  • Informed consent of the patient for adults and, parents or legal guardians for minors.
  • Affiliation to a social security system.
Exclusion Criteria
  • Non-francophone,
  • Severe intellectual impairment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupStandard follow-upstandard outpatient follow-up
Therapeutic educationTherapeutic educationStructured therapeutic education programs
Primary Outcome Measures
NameTimeMethod
PedsQL 4.0 scoreFollow up of patients over 12 months

Evolution of the quality of life assessed by PedsQL 4.0 self-reported scores from month 0 to month 12.

Secondary Outcome Measures
NameTimeMethod
Disease severityFollow up of patients over 12 months

The evolution of the severity of the disease from month 0 to month 12 was assessed by the degree of heart failure (NYHA functionnal class I to IV) and the number of hospitalizations (in stays and days) for complications related to the congenital heart disease

Anxiety and depressionFollow up of patients over 12 months

The evolution of the levels of depression and/or anxiety from month 0 to month 12 was assessed respectively by :

* the BDI (Beck Depression Inventory) for young adults

* the CDI (Child Depression Inventory) for adolescents

* the STAI (State and Trait Anxiety Inventory) for adults and STAI-C (Children) for adolescents.

A higher score is associated with a higher risk of depression/anxiety.

Ricci and Gagnon scoreFollow up of patients over 12 months

Evolution of the physical activity assessed by Ricci and Gagnon scores from month 0 to month 12. Ricci and Ganon score is a physical activity self-questionnaire with a total score out of 40 (\<16 points: not very active, between 16 and 32 points: fairly active, \> 32 points: very active).

Leuven Knowledge scoreFollow up of patients over 12 months

Evolution of the knowledge of the disease assessed by Leuven Knowledge scores from month 0 to month 12. The level of knowledge was assessed by the "transition readdiness assessment" instrument : 10-item questionnaire reflecting the basic knowledge of the diseases and its management.

Physiological parametersFollow up of patients over 12 months

Evolution of the physiological parameters during a cardiopulmonary exercise test performed on a treadmill according to a modified Bruce protocole. Evolution of the physiological parameters from month 0 to month 12

Trial Locations

Locations (1)

Pediatric and Congenital Cardiology and Pulmonology Department, Arnaud De Villeneuve University Hospital

🇫🇷

Montpellier, France

© Copyright 2025. All Rights Reserved by MedPath